In-Vivo Gene Editing Emerges as a New Direction for Cell & Gene Therapy
In-Vivo Gene Editing Emerges as a New Direction for Cell & Gene Therapy Introduction: A Shift in the Gene Therapy Paradigm Gene editing is entering…
Latest News
GLP-1 Success Is Reshaping Pharma Investment Priorities
GLP-1 Success Is Reshaping Pharma Investment Priorities Introduction: From Therapeutic Breakthrough to Strategic Investment Priority The rapid growth of glucagon-like peptide-1 (GLP-1) receptor agonists has…
CAR-T Moves Beyond Oncology
CAR-T Moves Beyond Oncology: Could Immune Reset Become the Next Frontier? By Eminent Global Research Solutions Chimeric antigen receptor T-cell (CAR-T) therapy has transformed…
AI Drug Discovery Faces the Challenge of Translating Data Into Clinical Success
Artificial intelligence is rapidly changing how pharmaceutical companies identify targets, design molecules, predict properties, and prioritize drug candidates. From protein-structure prediction and virtual screening to…
Pharma M&A Accelerates as Patent Cliff Pressure Builds
How loss-of-exclusivity exposure is reshaping pharmaceutical portfolio strategy, dealmaking, and competitive positioning The pharmaceutical M&A landscape is entering a strategically important phase. Large drugmakers are…
FDA Advances Electronic Submissions for Medical Device PMAs
The U.S. Food and Drug Administration (FDA) is taking another significant step toward modernizing the way medical device companies prepare and submit Premarket Approval Applications…
AI Enters Cosmetic Safety and Adverse-Event Monitoring
AI Enters Cosmetic Safety and Adverse-Event Monitoring: From Reactive Reporting to Predictive Cosmetovigilance The cosmetics industry is entering a new phase of safety management. As…
Cell & Gene Therapy 2030: From Scientific Innovation to Commercial Scale
Cell and gene therapy (CGT) has moved from being primarily an experimental frontier to an increasingly established therapeutic modality. The scientific question is no longer…
FDA Updates Regulations to Advance Alternatives to Animal Testing
Industry: Pharmaceuticals | Biotechnology | Regulatory Intelligence | Drug Development The U.S. Food and Drug Administration (FDA) has taken another significant step toward modernizing nonclinical…